Journal of Antivirals & Antiretrovirals

Journal of Antivirals & Antiretrovirals
Open Access

ISSN: 1948-5964

+44 1300 500008

Journal of Antivirals & Antiretrovirals : Citations & Metrics Report

Articles published in Journal of Antivirals & Antiretrovirals have been cited by esteemed scholars and scientists all around the world. Journal of Antivirals & Antiretrovirals has got h-index 22, which means every article in Journal of Antivirals & Antiretrovirals has got 22 average citations.

Following are the list of articles that have cited the articles published in Journal of Antivirals & Antiretrovirals.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Total published articles

59 57 32 59 77 13 11 20 37 22 37 55 22 12

Research, Review articles and Editorials

1 0 5 42 32 12 10 14 27 21 33 44 21 10

Research communications, Review communications, Editorial communications, Case reports and Commentary

48 57 27 17 45 1 1 6 10 1 4 11 1 2

Conference proceedings

0 0 0 0 0 0 35 51 125 100 191 0 125 177

Citations received as per Google Scholar, other indexing platforms and portals

98 160 172 269 223 172 219 195 170 116 60 36 26 58
Journal total citations count 2004
Journal impact factor 5.32
Journal 5 years impact factor 5.62
Journal cite score 5.3
Journal h-index 22
Journal h-index since 2019 17
Important citations (1101)

naga anusha p (2011) antiretroviral strategies for treatment of hiv. j antivir antiretrovir 1: 2.

hima bindu a, naga anusha p (2011) adverse effects of highly active anti-retroviral therapy (haart). j antivir antiretrovir 3: 060-064.

mtambo a, chan k, shen a, lima v, hogg r, et al. (2012) treatment limitations imposed by antiretroviral drug resistance mutations: implication for choices of first line regimens in resource‐limited settings. hiv medicine. 13: 141-147.

ngum nh, ngum an, jini ss (2015) opportunistic intestinal protozoan infections in hiv/aids patients on antiretroviral therapy in the north west region of cameroon. british microbiology research journal 7: 269-275.

singh dd, singh v (2015) prevalence of intestinal parasitic infections in hiv infected patients presenting with diarrhea and their association with cd4+ counts. international journal of applied sciences and biotechnology 3: 96-100.

aryee en (2012) intestinal parasitic infection in hiv-infected patients at different cd4 t-cell counts in an african rural and peri-urban setting (doctoral dissertation).

soumya d, hima bindu a (2011) opportunistic diseases as a consequence of hiv/aids. j aids clin res 2: 5.

naga anusha p (2011) antiretroviral strategies for treatment of hiv. j antivir antiretrovir 1: 2.

alemseged m, girma m (2015) prevalence and associated risk factors o f opportunistic intestinal parasites among hiv positive and negative individual s in south ethiopia: a case control study. baoj hiv 15: 2-7.

teklemariam z, abate d, mitiku h, dessie y (2013) prevalence of intestinal parasitic infection among hiv positive persons who are naive and on antiretroviral treatment in hiwot fana specialized university hospital, eastern ethiopia. isrn aids 11: 21-25.

elshabrawy ha (2010) development of instantaneous protection against sars-cov with implications for multiple rna viruses (doctoral dissertation, university of illinois at chicago).

de wit e, munster vj. nipah virus emergence, transmission, pathogenesis (2015) inglobal virology i-identifying and investigating viral diseases 29: 125-146

zahoor ba, mudie li (2015) the imperative to develop a human vaccine for the hendra virus in australia. infection ecology & epidemiology 29: 5.

aljofan m (2015) henipaviruses are not yet history. future virology 10: 507-515.

mathieu c, horvat b (2015) henipavirus pathogenesis and antiviral approaches. expert review of anti-infective therapy. 13: 343-354.

aljofan m (2013) hendra and nipah infection: emerging paramyxoviruses.virus research 177: 119-126.

aguilar hc, lee b (2011) emerging paramyxoviruses: molecular mechanisms and antiviral strategies. expert reviews in molecular medicine 13: e6.

mahalingam s, herrero lj, playford eg, spann k, herring b, et al. (2012) hendra virus: an emerging paramyxovirus in australia. the lancet infectious diseases. 12: 799-807.

batbold u, butov do, kutsyna ga, damdinpurev n, grinishina ea. double-blind, placebo-controlled, 1: 1 randomized phase iii clinical trial of immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosis. immunotherapy. 2017;9: 13-24.

naga anusha p, siddiqui a, hima bindu a. immuno defense mechanism against tumors. j cancer sci ther. 2011;s: 17: 2.

Top